abrdn Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$403M Sell
14,537,918
-4,305,890
-23% -$114M 1.36% 20
2017
Q1
$469M Sell
18,843,808
-904,489
-5% -$22M 1.55% 16
2016
Q4
$427M Buy
19,748,297
+257,738
+1% +$5.62M 1.49% 16
2016
Q3
$464M Sell
19,490,559
-195,788
-1% -$4.67M 1.91% 8
2016
Q2
$460M Sell
19,686,347
-286,634
-1% -$6.2M 2.08% 8
2016
Q1
$376M Sell
19,972,981
-108,159
-0.5% -$1.9M 1.71% 15
2015
Q4
$370M Buy
20,081,140
+902,531
+5% +$16.2M 1.57% 21
2015
Q3
$315M Sell
19,178,609
-9,687
-0.1% -$166K 1.35% 27
2015
Q2
$340M Buy
19,188,296
+10,724,080
+127% +$192M 1.44% 24
2015
Q1
$150M Buy
8,464,216
+4,805,367
+131% +$75.9M 0.61% 61
2014
Q4
$48.5M Buy
3,658,849
+855,241
+31% +$10.9M 0.19% 98
2014
Q3
$33.1M Buy
2,803,608
+682,639
+32% +$8.6M 0.13% 128
2014
Q2
$27.1M Buy
2,120,969
+2,062,408
+3,522% +$26.8M 0.12% 129
2014
Q1
$792K Sell
58,561
-107
-0.2% -$1.4K ﹤0.01% 290
2013
Q4
$705K Buy
58,668
+1,110
+2% +$13.1K ﹤0.01% 328
2013
Q3
$676K Sell
57,558
-898
-2% -$9.71K ﹤0.01% 323
2013
Q2
$542K Buy
+58,456
New +$496K ﹤0.01% 338

Other funds holding BSX

abrdn Investment Management's BSX Position: Q2 2017 in Review

abrdn Investment Management reduced its Boston Scientific (BSX) stake by 23% in Q2 2017, selling an estimated $114M and leaving 14,537,918 shares worth $403M. The position accounts for 1.36% of the portfolio, ranked #20.

abrdn Investment Management first reported a position in BSX in Q2 2013 and has held it in 17 quarters since. The position peaked at $469M in Q1 2017. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

  • abrdn Investment Management held 14,537,918 shares of Boston Scientific worth $403M as of Q2 2017.
  • abrdn Investment Management sold 4,305,890 Boston Scientific shares in Q2 2017, an estimated $114M.
  • Boston Scientific made up 1.36% of abrdn Investment Management's portfolio in Q2 2017, its #20 holding.
  • abrdn Investment Management first reported a position in Boston Scientific in Q2 2013 and has held it in 17 quarters since.
  • abrdn Investment Management's Boston Scientific position peaked at $469M in Q1 2017.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.